查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968595

基层医疗即时诊断市场分析及预测（至2035年）：按类型、产品类型、服务、技术、应用、最终用户、设备、部署类型、安装类型和解决方案照护现场

Primary Care PoC Diagnostics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Device, Deployment, Installation Type, Solutions
出版日期: | 出版商: Global Insight Services | 英文 422 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，基层医疗即时诊断（PoC）市场规模将从2024年的197亿美元成长至267亿美元，复合年增长率约为3.1%。基层医疗PoC诊断市场涵盖分散式检查解决方案，可在诊疗现场快速提供诊断结果。这些工具能够帮助基层医疗提供者更快地做出决策，从而提升患者管理水平并支持其工作。推动该市场成长的因素包括技术进步、慢性病盛行率上升以及以患者为中心的医疗保健模式的转变。为了满足日益增长的对高效、经济的医疗保健服务的需求，创新正致力于提高诊断技术的准确性、连接性和易用性。

基层医疗即时诊断市场正经历强劲成长，这主要得益于人们对快速、精准诊断解决方案日益增长的需求。传染病检查细分市场是成长最快的子细分市场，其成长动力主要来自对快速感染疾病检测和管理的日益增长的需求。在该细分市场中，呼吸道感染和性行为感染感染检测尤为突出，反映出人们预防保健意识的提高和相关措施的进步。血液检测是第二大细分市场，受益于技术进步和血液相关疾病的日益增加。数位技术和连接解决方案的整合正在提升即时诊断的能力，实现即时数据共用和更完善的患者管理。微流体和生物感测器的创新进一步拓展了诊断能力，提供了更全面、更微创的检测选择。随着医疗保健系统日益注重以患者为中心的护理，对高效、分散式诊断解决方案的需求预计将推动市场成长，为相关人员创造丰厚的成长机会。

市场区隔
类型 横向流动化验、免疫检测、分子诊断、血液学、临床化学、微生物学、血液凝固检验、尿液检查
产品 仪器、试剂盒、试剂、耗材、软体
服务 安装、维护、训练、咨询、资料管理
科技 生物感测器、微流体、实验室晶片、核酸扩增、电化学检测
应用领域 感染疾病、慢性病科、肿瘤科、心臟科、内分泌科、消化科、肾臟科、小儿科、妇科
最终用户 医院、诊所、门诊中心、居家医疗机构、检查室、药房和研究实验室
装置 手持式、桌上型、可携式、可穿戴式
实施表格 本机部署、云端部署、混合式部署
安装类型 新安装、维修和升级
解决方案 数据整合、远端监控、病患管理、品管、工作流程优化

市场概况：

基层医疗照护现场诊断市场呈现出市场份额分布多元化的特点，这主要受策略定价和创新产品发布的影响。各公司正致力于透过提供先进的诊断解决方案来拓展产品组合，从而增强自身的竞争优势。基层医疗机构对快速、准确诊断的需求日益增长，推动了就地检验（POC​​T）的快速发展。技术进步以及需要及时干预和监测的慢性病病例的增加进一步促进了这一趋势。竞争基准分析揭示了一个动态的市场环境，主要参与者正透过策略联盟和收购来争夺主导。监管的影响至关重要，严格的标准确保了诊断工具的可靠性和安全性。不同地区的监管环境差异塑造了市场格局，影响产品核可和打入市场策略。各公司正利用这些洞察来优化其市场定位，同时应对复杂的法规结构。诊断技术的创新进一步重塑了竞争格局，提供了成长机会和差异化优势。

主要趋势和驱动因素：

受技术进步和慢性病发病率上升的推动，基层医疗即时诊断（PoC）市场正经历强劲增长。关键趋势包括人工智慧（AI）和机器学习的日益融合，这提高了诊断准确性和营运效率。对快速诊断和治疗的需求推动了对快速检测解决方案的需求，尤其是在农村和医疗资源匮乏的地区。此外，随着个人化医疗的兴起，诊断技术在製定针对每位患者需求的个人化治疗方案中发挥关键作用。对预防性护理的日益重视也推动了PoC诊断的普及，因为早期发现对于健康管理至关重要。不断上涨的医疗成本和政府的支持性政策进一步推动了市场扩张。新兴市场医疗基础设施的快速发展蕴藏着许多机会。专注于提供价格合理且便携的诊断解决方案的公司有望占据可观的市场份额。此外，居家检测的趋势也为市场成长开闢了新的途径，满足了日益注重健康的消费者对便利高效检测的需求。

限制与挑战：

基层医疗即时诊断市场面临许多重大限制和挑战。其中一项主要挑战是严格的监管环境，这可能会延缓新型诊断测试的核准和商业化。这种复杂的监管环境通常会导致市场准入成本增加和批准週期延长。另一项挑战是限制性的报销政策，这可能会因资金限製而阻碍医疗机构采用这些诊断技术。此外，技术挑战也不容忽视，因为整合先进技术需要大量的投资和专业知识。另外，各地区缺乏标准化的通讯协定，也增加了诊断流程执行和一致性的难度。最后，资料隐私问题和网路安全威胁构成重大风险，因为强而有力的安全措施对于保护敏感的病患资讯至关重要。这些挑战共同阻碍了市场的成长潜力，亟需制定策略性解决方案来克服这些挑战。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 横向流动化验
    • 免疫检测
    • 分子诊断
    • 血液学
    • 临床化学
    • 微生物学
    • 凝血
    • 尿液检查
  • 市场规模及预测：依产品划分
    • 装置
    • 成套工具
    • 试剂
    • 消耗品
    • 软体
  • 市场规模及预测：依服务划分
    • 安装
    • 维护和检查
    • 训练
    • 咨询
    • 资料管理
  • 市场规模及预测：依技术划分
    • 生物感测器
    • 微流体技术
    • 实验室晶片
    • 核酸扩增
    • 电化学检测
  • 市场规模及预测：依应用领域划分
    • 感染疾病
    • 慢性病
    • 肿瘤学
    • 心臟病学
    • 内分泌学
    • 胃肠病学
    • 肾臟病学
    • 儿童
    • 妇科
  • 市场规模及预测：依最终用户划分
    • 医院
    • 按部门
    • 门诊治疗中心
    • 居家医疗
    • 诊断检查室
    • 药局
    • 研究所
  • 市场规模及预测：依设备划分
    • 手持式
    • 工作台
    • 可携式的
    • 穿戴式装置
  • 市场规模及预测：依发展状况
    • 本地部署
    • 基于云端的
    • 杂交种
  • 市场规模及预测：依安装类型划分
    • 新推出
    • 改装
    • 升级
  • 市场规模及预测：按解决方案划分
    • 数据集成
    • 远端监控
    • 病患管理
    • 品管
    • 优化您的工作流程

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • QuidelOrtho
  • Bio-Rad Laboratories
  • Cepheid
  • BioMerieux
  • Hologic
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Beckman Coulter
  • Nova Biomedical
  • Alere
  • Randox Laboratories
  • Sekisui Diagnostics
  • Trinity Biotech
  • Meridian Bioscience
  • EKF Diagnostics
  • Luminex Corporation

第九章：关于我们

简介目录
Product Code: GIS33196

Primary Care PoC Diagnostics Market is anticipated to expand from $19.7 billion in 2024 to $26.7 billion by 2034, growing at a CAGR of approximately 3.1%. The Primary Care PoC Diagnostics Market encompasses decentralized testing solutions that deliver rapid diagnostic results at the point of care. These tools empower primary care providers by enhancing patient management through swift decision-making. The market is driven by technological advancements, increasing chronic disease prevalence, and a shift towards patient-centric healthcare. Innovations focus on improving accuracy, connectivity, and ease of use, aligning with the growing demand for efficient, cost-effective healthcare delivery.

The Primary Care PoC Diagnostics Market is experiencing robust growth, propelled by an increasing emphasis on rapid and accurate diagnostic solutions. The infectious disease testing segment is the top-performing sub-segment, driven by the rising need for swift disease detection and management. Within this segment, tests for respiratory infections and sexually transmitted infections are particularly prominent, reflecting heightened awareness and preventive healthcare measures. The second-highest performing sub-segment is hematology testing, which benefits from technological advancements and the increasing prevalence of blood-related disorders. The integration of digital technologies and connectivity solutions is enhancing the capabilities of PoC diagnostics, allowing for real-time data sharing and improved patient management. Innovations in microfluidics and biosensors are further expanding diagnostic possibilities, offering more comprehensive and less invasive testing options. As healthcare systems increasingly prioritize patient-centric care, the demand for efficient, decentralized diagnostic solutions is expected to drive market growth, presenting lucrative opportunities for stakeholders.

Market Segmentation
TypeLateral Flow Assays, Immunoassays, Molecular Diagnostics, Hematology, Clinical Chemistry, Microbiology, Coagulation, Urinalysis
ProductInstruments, Kits, Reagents, Consumables, Software
ServicesInstallation, Maintenance, Training, Consultation, Data Management
TechnologyBiosensors, Microfluidics, Lab-on-a-chip, Nucleic Acid Amplification, Electrochemical Detection
ApplicationInfectious Diseases, Chronic Diseases, Oncology, Cardiology, Endocrinology, Gastroenterology, Nephrology, Pediatrics, Gynecology
End UserHospitals, Clinics, Ambulatory Care Centers, Home Care, Diagnostic Laboratories, Pharmacies, Research Institutes
DeviceHandheld, Benchtop, Portable, Wearable
DeploymentOn-premise, Cloud-based, Hybrid
Installation TypeNew Installation, Retrofit, Upgrade
SolutionsData Integration, Remote Monitoring, Patient Management, Quality Control, Workflow Optimization

Market Snapshot:

In the Primary Care PoC Diagnostics Market, the landscape is characterized by diverse market share distribution, influenced by strategic pricing and the launch of innovative products. Companies are focusing on expanding their portfolios with advanced diagnostic solutions, enhancing their competitive edge. The market is witnessing a surge in demand for point-of-care testing, driven by the need for rapid and accurate diagnostics in primary care settings. This trend is further propelled by technological advancements and the increasing prevalence of chronic diseases, which necessitate timely intervention and monitoring. Competition benchmarking reveals a dynamic environment, with key players vying for dominance through strategic partnerships and acquisitions. Regulatory influences play a pivotal role, as stringent standards ensure the reliability and safety of diagnostic tools. The market is shaped by varying regulatory landscapes across regions, impacting product approvals and market entry strategies. Companies are leveraging these insights to navigate the complex regulatory frameworks, optimizing their market positioning. The competitive landscape is further defined by innovation in diagnostic technologies, offering significant opportunities for growth and differentiation.

Geographical Overview:

The Primary Care Point-of-Care (PoC) Diagnostics Market is witnessing substantial growth across diverse regions, each presenting unique opportunities. North America leads this market, driven by an increasing demand for rapid diagnostic solutions in primary healthcare settings. The region's robust healthcare infrastructure and technological advancements contribute to its dominance. Europe follows, with a strong focus on enhancing patient care and reducing healthcare costs. The region's emphasis on early diagnosis and preventive care bolsters the market's expansion. In the Asia Pacific, burgeoning healthcare needs and rising awareness about PoC diagnostics are fueling growth. Emerging economies like India and China are pivotal, given their large populations and improving healthcare access. Latin America and the Middle East & Africa are burgeoning markets with untapped potential. Latin America's growing healthcare investments and the Middle East & Africa's increasing focus on healthcare innovation present lucrative opportunities for market players aiming to expand their global footprint.

Key Trends and Drivers:

The Primary Care PoC Diagnostics Market is experiencing robust growth, driven by technological advancements and the rising prevalence of chronic diseases. Key trends include the integration of artificial intelligence and machine learning, enhancing diagnostic accuracy and operational efficiency. The demand for rapid testing solutions is increasing, fueled by the need for timely diagnosis and treatment, particularly in rural and underserved areas. Furthermore, the market is witnessing a shift towards personalized medicine, with diagnostics playing a crucial role in tailoring treatments to individual patient needs. The emphasis on preventive healthcare is also propelling the adoption of PoC diagnostics, as early detection becomes paramount in managing health outcomes. Increasing healthcare expenditure and supportive government policies are further bolstering market expansion. Opportunities abound in emerging markets, where healthcare infrastructure is developing rapidly. Companies focusing on affordable and portable diagnostic solutions are well-positioned to capture significant market share. Additionally, the growing trend of home-based testing presents new avenues for market growth, catering to the needs of an increasingly health-conscious population seeking convenience and efficiency.

Restraints and Challenges:

The Primary Care PoC Diagnostics Market encounters several significant restraints and challenges. A primary challenge is the stringent regulatory landscape, which can delay the approval and commercialization of new diagnostic tests. This regulatory complexity often results in increased costs and extended timeframes for market entry. Another challenge is the limited reimbursement policies, which can deter healthcare providers from adopting these diagnostics due to financial constraints. The market also faces technological challenges, as the integration of advanced technologies requires substantial investment and expertise. Additionally, there is a lack of standardized protocols across different regions, complicating the implementation and consistency of diagnostic procedures. Lastly, data privacy concerns and cybersecurity threats pose significant risks, as sensitive patient information must be protected, requiring robust security measures. These challenges collectively hinder the market's growth potential and necessitate strategic solutions to overcome them.

Key Players:

QuidelOrtho, Bio-Rad Laboratories, Cepheid, BioMerieux, Hologic, Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Sysmex Corporation, Ortho Clinical Diagnostics, Beckman Coulter, Nova Biomedical, Alere, Randox Laboratories, Sekisui Diagnostics, Trinity Biotech, Meridian Bioscience, EKF Diagnostics, Luminex Corporation

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Installation Type
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Lateral Flow Assays
    • 4.1.2 Immunoassays
    • 4.1.3 Molecular Diagnostics
    • 4.1.4 Hematology
    • 4.1.5 Clinical Chemistry
    • 4.1.6 Microbiology
    • 4.1.7 Coagulation
    • 4.1.8 Urinalysis
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Kits
    • 4.2.3 Reagents
    • 4.2.4 Consumables
    • 4.2.5 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Installation
    • 4.3.2 Maintenance
    • 4.3.3 Training
    • 4.3.4 Consultation
    • 4.3.5 Data Management
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Biosensors
    • 4.4.2 Microfluidics
    • 4.4.3 Lab-on-a-chip
    • 4.4.4 Nucleic Acid Amplification
    • 4.4.5 Electrochemical Detection
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Infectious Diseases
    • 4.5.2 Chronic Diseases
    • 4.5.3 Oncology
    • 4.5.4 Cardiology
    • 4.5.5 Endocrinology
    • 4.5.6 Gastroenterology
    • 4.5.7 Nephrology
    • 4.5.8 Pediatrics
    • 4.5.9 Gynecology
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Clinics
    • 4.6.3 Ambulatory Care Centers
    • 4.6.4 Home Care
    • 4.6.5 Diagnostic Laboratories
    • 4.6.6 Pharmacies
    • 4.6.7 Research Institutes
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Handheld
    • 4.7.2 Benchtop
    • 4.7.3 Portable
    • 4.7.4 Wearable
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-premise
    • 4.8.2 Cloud-based
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by Installation Type (2020-2035)
    • 4.9.1 New Installation
    • 4.9.2 Retrofit
    • 4.9.3 Upgrade
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Data Integration
    • 4.10.2 Remote Monitoring
    • 4.10.3 Patient Management
    • 4.10.4 Quality Control
    • 4.10.5 Workflow Optimization

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Device
      • 5.2.1.8 Deployment
      • 5.2.1.9 Installation Type
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Device
      • 5.2.2.8 Deployment
      • 5.2.2.9 Installation Type
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Device
      • 5.2.3.8 Deployment
      • 5.2.3.9 Installation Type
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Device
      • 5.3.1.8 Deployment
      • 5.3.1.9 Installation Type
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Device
      • 5.3.2.8 Deployment
      • 5.3.2.9 Installation Type
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Device
      • 5.3.3.8 Deployment
      • 5.3.3.9 Installation Type
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Device
      • 5.4.1.8 Deployment
      • 5.4.1.9 Installation Type
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Device
      • 5.4.2.8 Deployment
      • 5.4.2.9 Installation Type
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Device
      • 5.4.3.8 Deployment
      • 5.4.3.9 Installation Type
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Device
      • 5.4.4.8 Deployment
      • 5.4.4.9 Installation Type
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Device
      • 5.4.5.8 Deployment
      • 5.4.5.9 Installation Type
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Device
      • 5.4.6.8 Deployment
      • 5.4.6.9 Installation Type
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Device
      • 5.4.7.8 Deployment
      • 5.4.7.9 Installation Type
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Device
      • 5.5.1.8 Deployment
      • 5.5.1.9 Installation Type
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Device
      • 5.5.2.8 Deployment
      • 5.5.2.9 Installation Type
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Device
      • 5.5.3.8 Deployment
      • 5.5.3.9 Installation Type
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Device
      • 5.5.4.8 Deployment
      • 5.5.4.9 Installation Type
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Device
      • 5.5.5.8 Deployment
      • 5.5.5.9 Installation Type
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Device
      • 5.5.6.8 Deployment
      • 5.5.6.9 Installation Type
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Device
      • 5.6.1.8 Deployment
      • 5.6.1.9 Installation Type
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Device
      • 5.6.2.8 Deployment
      • 5.6.2.9 Installation Type
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Device
      • 5.6.3.8 Deployment
      • 5.6.3.9 Installation Type
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Device
      • 5.6.4.8 Deployment
      • 5.6.4.9 Installation Type
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Device
      • 5.6.5.8 Deployment
      • 5.6.5.9 Installation Type
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 QuidelOrtho
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio-Rad Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Cepheid
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 BioMerieux
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Hologic
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Roche Diagnostics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Abbott Laboratories
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Siemens Healthineers
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Thermo Fisher Scientific
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Sysmex Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Ortho Clinical Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Beckman Coulter
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nova Biomedical
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Alere
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Randox Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Sekisui Diagnostics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Trinity Biotech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Meridian Bioscience
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 EKF Diagnostics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Luminex Corporation
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us